Research Peptide Quality Checklist: Verify CoA Authenticity

When you receive a certificate of analysis (CoA) for a research peptide, the document itself is not proof of quality—it is a set of claims that must be verified. This research peptide quality checklist walks through the operational steps a procurement or QA reviewer should take to confirm that a CoA is authentic, internally consistent, and traceable to the lot you are purchasing. It focuses on the fields most often falsified and the cross-checks that expose inconsistencies.

Why CoA Authentication Matters in Research Procurement

Institutional buyers use CoAs to document lot-specific identity, purity, and testing conditions for preclinical and laboratory research. A forged or recycled CoA can introduce uncontrolled variables into studies, invalidate internal traceability records, and create compliance exposure. Unlike consumer supplements, research peptides are often purchased in small batches with custom synthesis, so the CoA is frequently the only bridge between the vial and the analytical data.

Suppliers vary widely in how they generate and share CoAs. Some provide third-party laboratory reports with full chromatograms and spectra; others issue internally generated summaries with no raw data. The checklist below is designed to help you distinguish between these cases before you commit to a purchase order.

Field-by-Field CoA Verification Checklist

Use the following sequence when reviewing any CoA. Each item is a potential failure point, and the order reflects how falsifications are typically layered—superficial fields are easiest to fake, while raw data and cross-references are harder to sustain.

1. Lot and Product Identifiers

• Lot/batch number: Confirm it matches the number on the vial label, the packing slip, and any accompanying shipping documents. Falsified CoAs often reuse a lot number from a previous batch or omit it entirely.
• Product name and sequence: Check that the peptide name, amino acid sequence, and molecular formula are consistent with your order. A common error is a CoA for a related analog (e.g., a different GLP-1 receptor agonist) being substituted for the ordered item.
• Manufacturer and testing site: The CoA should identify who manufactured the lot and where testing was performed. If the testing laboratory is not named, request the report directly from the lab.

2. Analytical Methods and Raw Data

This is where most low-quality CoAs fall apart. A credible CoA includes the method used and the actual data, not just a summary number.

• HPLC purity: Look for the column type, mobile phase, gradient, detection wavelength (typically 214 nm or 220 nm for peptides), and injection volume. The chromatogram should show a single main peak with baseline resolution and a reported purity percentage. A purity claim without an attached chromatogram is unverifiable.
• Mass spectrometry: Confirm the expected molecular weight and the observed mass. For peptides, ESI-MS or MALDI-TOF reports should include the m/z values and the calculated mass. A discrepancy greater than 0.5 Da warrants explanation.
• Counter-ion and salt form: Many peptides are supplied as acetate or TFA salts. The CoA should state the salt form and, where relevant, the counter-ion content. This affects solubility and assay interpretation.
• Water content and appearance: Karl Fischer titration or loss on drying, plus a visual description, are standard. Missing water content can indicate a copied template.

For a deeper walkthrough of HPLC and mass spec interpretation specific to tirzepatide, see our tirzepatide CoA guide. For general CoA reading guidance, the CoA guide covers document structure and common red flags.

3. Laboratory Identity and Accreditation

• Named laboratory: The testing lab should be identifiable, with a location and contact information. Generic labels like “third-party lab” without a name are a red flag.
• Accreditation status: Check whether the lab holds ISO/IEC 17025 accreditation for the relevant methods. Accreditation is not a guarantee of authenticity, but it provides a verifiable audit trail.
• Report date and version: Confirm the report date is after the manufacturing date and that no later revision exists. Falsified CoAs sometimes carry dates that precede synthesis.

4. Internal Consistency Checks

Cross-check the CoA against itself and against the physical product. Inconsistencies are often the fastest way to detect a fabricated document.

• Purity vs. chromatogram: The reported purity percentage should match the peak area integration shown in the chromatogram. If the chromatogram shows multiple peaks but purity is listed at 99%, question it.
• Mass vs. sequence: Calculate the theoretical mass from the amino acid sequence and compare it to the observed mass. This is a simple but powerful check.
• Vial fill and label: The net peptide content (mg per vial) should align with the label claim and the CoA. Consider whether the fill volume and concentration are plausible for the peptide’s solubility.

5. Traceability and Chain of Custody

• Manufacturing date and expiry: Confirm these are present and consistent with storage recommendations.
• Storage and shipping conditions: The CoA should state recommended storage (e.g., -20°C, desiccated) and any special handling. Missing storage information is common in template-generated CoAs.
• Retest or reanalysis history: If the lot was reanalyzed, the CoA should indicate the original and retest dates. Undisclosed retesting can mask stability issues.

Common Falsification Patterns and How to Detect Them

From a QA review perspective, most CoA falsifications fall into a few patterns. Recognizing them speeds up verification.

• Template reuse: Identical chromatograms or spectra across different lots or products. Compare peak shapes and retention times; genuine analyses vary slightly.
• Copy-paste mass spec: Observed masses that are rounded or inconsistent with the sequence. Always recalculate.
• Missing raw data: CoAs that report only a purity percentage without chromatograms or spectra. Request the full report.
• Unverifiable lab names: Labs that cannot be found online or that lack contact details. Call the lab directly to confirm the report number.
• Date anomalies: Report dates that precede manufacturing or that are identical across multiple lots produced months apart.

When in doubt, request the original PDF from the testing laboratory, not a scanned image from the supplier. Scanned images are easier to alter and harder to authenticate.

Building a Supplier Verification Protocol

A one-time CoA check is useful, but institutional buyers benefit from a repeatable protocol. Consider the following steps for each new supplier or lot:

• Request a sample CoA before placing a first order and run the checklist above.
• Ask for the testing laboratory’s contact information and confirm the report number directly.
• Compare CoAs across multiple lots to detect template reuse.
• Document your verification steps in your internal procurement record.
• For high-value or critical lots, consider independent third-party testing at a lab of your choice.

Helix Peptide supports institutional buyers with lot-specific documentation and direct access to QA for CoA verification questions. If you need to confirm testing details or request a quote, contact our QA team.

Conclusion: A Checklist Approach to Research Peptide Quality

Verifying a CoA is not about trusting a document—it is about applying a consistent research peptide quality checklist that tests internal consistency, traceability, and raw data. By focusing on lot identifiers, analytical methods, laboratory identity, and cross-checks, procurement teams can reduce the risk of accepting falsified or low-quality documentation. Use this checklist as a starting point, adapt it to your institution’s requirements, and always request raw data when a claim cannot be independently confirmed.

Ready to review lot documentation or request a quote? Contact Helix Peptide to speak with our QA and procurement team.